As of Jun 02
| +0.07 / +1.23%|
The 3 analysts offering 12-month price forecasts for Harvard Bioscience Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 6.75. The median estimate represents a +21.53% increase from the last price of 5.76.
The current consensus among 3 polled investment analysts is to Buy stock in Harvard Bioscience Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.